6505--Cyclobenzaprine Tablets (VA-25-00015093)
ID: 36E79725R0009Type: Presolicitation
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OFNAC PHARMACEUTICALS (36E797)HINES, IL, 60141, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

DRUGS AND BIOLOGICALS (6505)

Original Source

https://sam.gov/opp/4fa277e7746e400fa013fc2a324df35a/view
Timeline
    Description

    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Cyclobenzaprine HCL Tablets under solicitation number 36E79725R0009. This unrestricted procurement aims to secure a reliable supply of these essential pharmaceuticals for the VA, Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Center (FHCC), reflecting the government's commitment to providing necessary medications to veterans and associated healthcare systems. The contract will have an initial duration of one year, with the possibility of four additional one-year extensions, and interested vendors must provide specific drug labeling along with a unique National Drug Code (NDC). The RFP is expected to be released electronically around December 20, 2024, with a submission deadline set for January 3, 2025. For further inquiries, interested parties can contact Kenneth Lay at Kenneth.Lay@va.gov or by phone at 708-786-4879.

    Point(s) of Contact
    Kenneth LayContract Specialist
    (708) 786-4879
    Kenneth.Lay@va.gov
    Files
    Title
    Posted
    36E79725R0009.docx
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for Cyclobenzaprine HCL Tablets under solicitation number 36E79725R0009. This unrestricted procurement aims to secure a consistent supply of these pharmaceuticals for not only the VA but also for the Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Center (FHCC). The contract will span one year with four optional one-year extensions. Vendors must provide specific drug labeling and a unique National Drug Code (NDC). The RFP will be released electronically around December 20, 2024, with a submission deadline of January 3, 2025. Interested suppliers can obtain further information and amendments via sam.gov. The document outlines estimated annual usage for various package sizes of Cyclobenzaprine HCL Tablets, indicating substantial demand across different formats. This procurement reflects the government's commitment to ensuring that veterans and associated health care systems have access to essential medications.
    Lifecycle
    Title
    Type
    6505--Cyclobenzaprine Tablets (VA-25-00015093)
    Currently viewing
    Presolicitation
    Similar Opportunities
    6505--Carbidopa/Levodopa SA Tablet
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) intends to issue a Request for Proposal (RFP) 36E79725R0008 for the procurement of Carbidopa/Levodopa sustained release (SA) tablets, aimed at ensuring a continuous supply of these medications for various federal health services, including the Department of Defense and the Bureau of Prisons. The contract will be awarded for an initial period of one year, with the option to extend for four additional one-year periods, requiring offerors to provide unique branding and packaging without overlapping labels. The estimated annual usage totals approximately 119,875 bottles across two dosage forms, highlighting the importance of these medications in treating Parkinson's disease and related conditions. Interested parties should note that the electronic solicitation is expected to be issued around January 3, 2026, with offers due by January 17, 2026; questions can be directed to the contracting officer, Chris Carthron, at Christopher.Carthron@va.gov.
    6505--Tamsulosin Capsules
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is issuing a presolicitation notice for Request for Proposal (RFP) 36E79725R0011 concerning the procurement of Tamsulosin Hydrochloride (HCL) Capsules. This procurement aims to ensure an uninterrupted supply of Tamsulosin HCL for the VA, Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and other federal healthcare facilities, with one contract awarded to a responsible offeror capable of meeting these needs over a base period of one year, plus four optional one-year extensions. The estimated annual requirements include approximately 1.4 million bottles of 90-count Tamsulosin HCL 0.4mg capsules, along with options for larger packaging sizes, highlighting the importance of consistent medicinal supply for veteran healthcare. Interested vendors should note that the solicitation will be released electronically on or about January 7, 2025, with responses due by January 21, 2025; inquiries can be directed to Contract Specialist Andrew Cazares at Andrew.Cazares@va.gov or (708) 786-4990.
    6505--Verapamil Hydrochloride (HCL) Tablets
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting offers for the procurement of Verapamil Hydrochloride (HCL) Tablets, aimed at establishing a contract for the supply of this pharmaceutical product through the VA and Department of Defense Pharmaceutical Prime Vendor Programs. The solicitation requires bidders to provide pricing for the base year and four option years, ensuring compliance with current Good Manufacturing Practices (cGMP) and adherence to FDA regulations, including drug registration and barcoding requirements. This procurement is crucial for maintaining the supply of essential medications for VA healthcare needs. Interested parties must submit their offers by December 24, 2024, at 2:30 PM CST, and can direct inquiries to Contract Specialist Nicholas I. McGregor at Nicholas.McGregor@va.gov.
    6505--765_Pharmaceuticals_VA CMOP Hines_36C77025Q0088 765-25-1-021-0194 -Hines CMOP 4 PHARMACEUTICALS -(VA-25-00028394)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified vendors to supply various pharmaceuticals for delivery to the Consolidated Mail Outpatient Pharmacy (CMOP) in Hines, Illinois, under solicitation number 36C77025Q0088. The procurement includes specific items such as PEG-400 solution, Sevelamer carbonate tablets, Fenofibrate capsules, and Febuxostat tablets, with a total quantity specified for each item. These pharmaceuticals are essential for ensuring the health and well-being of veterans, highlighting the importance of a reliable supply chain in the healthcare sector. Interested vendors must submit their quotes, including a signed SF 1449 cover page and compliance documentation, by December 27, 2024, at 9:00 AM CST, with the estimated award date set for December 31, 2024. For further inquiries, vendors can contact Jeffrey A. Blackard at jeffrey.blackard@va.gov or by phone at (913) 684-0142.
    6505--Abiraterone Tablets
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is soliciting proposals for the supply of Abiraterone Acetate Tablets through its Pharmaceutical Prime Vendor Program. Offerors are required to comply with the Drug Supply Chain Security Act (DSCSA) and Good Manufacturing Practices (cGMP), providing a unique 11-digit National Drug Code (NDC) for each drug, along with pricing for the base year and four optional years, including a Cost Recovery Fee. This procurement is crucial for ensuring consistent availability and competitive pricing of essential medications for federal healthcare users, particularly veterans. Interested parties must submit their proposals by the extended deadline of January 8, 2025, at 2:30 PM CST, and can contact Contract Specialist Richard Mahario at Richard.Mahario@va.gov for further information.
    6505--770_Pharmaceuticals_VA CMOP National Office_36C77025Q0099 770-25-1-801-0137 -National CMOP FENOFIBRATE
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is seeking qualified vendors to fulfill an emergency procurement of Fenofibrate Pharmaceuticals for the Consolidated Mail Outpatient Pharmacy (CMOP), under solicitation number 36C77025Q0099. The procurement requires multiple quantities of Fenofibrate 145MG 90CT, with specific delivery to various CMOP facilities across the United States, emphasizing compliance with the Buy American statute. This initiative is crucial for ensuring the availability of essential pharmaceuticals for veterans, reflecting the VA's commitment to providing timely medical supplies. Interested vendors must submit their proposals by December 30, 2024, at 09:00 AM CST, including a signed SF1449 cover page, a detailed price schedule in Excel format, proof of state wholesale distributor licensure, and a completed Buy American certificate, with all submissions directed to Contract Specialist Michael W. McAlhaney at Michael.McAlhaney@va.gov.
    6505--761-25-1-015-0002 -Chelmsford CMOP 7 PHARMACEUTICALS (VA-25-00012193)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is seeking qualified vendors to supply thirteen specific pharmaceuticals for delivery to the Chelmsford Consolidated Mail Outpatient Pharmacy (CMOP) in Massachusetts. The procurement includes items such as Clomiphene Citrate and various Amlodipine/Benzapril combinations, with strict requirements for compliance with the Drug Supply Chain Security Act and a minimum one-year shelf life upon delivery. This initiative is crucial for maintaining an adequate pharmaceutical inventory to support the healthcare needs of veterans. Interested vendors must submit their proposals by December 2, 2024, including a signed SF1449 form, a completed pricing schedule, proof of a valid State Wholesale Distributor License, and a Trade Agreements Act certificate, directed to Contracting Officer Kelley Cunningham at kelley.cunningham@va.gov.
    6509--Warfarin Tablets (VA-25-00012328)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is seeking proposals for the supply of Warfarin NA tablets under solicitation number VA-25-00012328. The objective of this procurement is to establish a reliable supply contract for Warfarin tablets to ensure consistent availability and pricing through the VA and Department of Defense's Pharmaceutical Prime Vendor Programs. This initiative is crucial for maintaining a steady supply of essential pharmaceuticals, thereby supporting the government’s commitment to high-quality patient care and regulatory compliance. Interested offerors must submit their proposals by December 31, 2024, at 2:30 PM CST, and should direct any inquiries to Contracting Officer Adrienne A Albachiara at Adrienne.Albachiara@va.gov.
    6505--762_Pharmaceuticals_VA CMOP Tucson_36C77025Q0060 762-25-1-040-0111 -Tucson CMOP MIRTAZAPINE -(VA-25-00015396)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified vendors to supply Mirtazapine 7.5mg tablets for delivery to the Tucson CMOP facility under solicitation number 36C77025Q0060. The procurement requires a total quantity of 5,280 tablets and emphasizes compliance with the Drug Supply Chain Security Act (DSCSA), as well as adherence to the Buy American statute, necessitating separate quotes for foreign and domestic products. This acquisition is crucial for ensuring a reliable supply of pharmaceuticals to support the health programs of veterans, with a response deadline set for December 27, 2024, and an estimated award date of December 31, 2024. Interested vendors must submit their quotes, including a signed SF1449 form, a completed price schedule in Excel format, and proof of state wholesale distributor licensure, to Jeffrey Blackard at jeffrey.blackard@va.gov.
    Rizatriptan Benzoate
    Active
    Dept Of Defense
    Presolicitation DEPT OF DEFENSE is planning to issue a national requirements contract for Rizatriptan Benzoate tablets. The contract will establish a national supply source to provide the items listed in the schedule for purchase by Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons customers. The contract will be a firm-fixed price, requirements type contract with a one year base and four one year options. The solicitation will be posted on the DLA Bid Board System and SAM.gov. Interested parties should contact Keith Ryales for any questions/comments. The projected solicitation date is June 2022.